| 2008 JASN IMPACT FACTOR 7.505 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Epidemiology |
United States Renal Data System Coordinating Center, Minneapolis, Minnesota
Correspondence: Dr. Robert N. Foley, United States Renal Data System, 914 South 8th Street, Suite S-253, Minneapolis, MN 55404. Phone: 612-347-5979; Fax: 612-347-5878; E-mail: rfoley{at}usrds.org
Received for publication December 28, 2006. Accepted for publication May 24, 2007.
Whether the creatinine-based glomerular filtration rate (GFR) thresholds used to define chronic kidney disease (CKD) identify metabolic abnormalities similarly in minority and nonminority populations is unknown. We addressed this question among adult participants in the Third National Health and Nutrition Examination Survey (NHANES III) (n = 15,837). GFR was estimated from serum creatinine values and metabolic abnormalities were defined by 5th or 95th percentile values. After adjustment for age, demographic characteristics, and GFR, black participants were significantly more likely than white participants to have abnormal levels of systolic and diastolic blood pressure, hemoglobin, phosphorus, and uric acid. Hispanic subjects were significantly more likely to have abnormal levels of systolic blood pressure, hemoglobin, bicarbonate, and phosphorus. Among participants with GFR < 60 mL/min per 1.73 m2, black participants were significantly more likely to have abnormal levels of systolic and diastolic blood pressure, hemoglobin, and uric acid; Hispanic subjects were significantly more likely to have abnormal systolic blood pressure levels. Metabolic abnormalities were more common in minority populations, and low GFR appeared to have a multiplicative effect. Defining CKD using a single GFR threshold may be disadvantageous for minority populations because metabolic abnormalities are present at higher levels of GFR.
This article has been cited by other articles:
![]() |
A. D. Rule, B. L. Fridley, S. C. Hunt, Y. Asmann, E. Boerwinkle, J. S. Pankow, T. H. Mosley, and S. T. Turner Genome-wide linkage analysis for uric acid in families enriched for hypertension Nephrol. Dial. Transplant., August 1, 2009; 24(8): 2414 - 2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, T. H. Mosley, A. Alonso, and X. Huang Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study Am. J. Epidemiol., May 1, 2009; 169(9): 1064 - 1069. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Gadegbeku and G. M. Chertow Cum Hoc, Ergo Propter Hoc: Health Disparities Real and Imagined Clin. J. Am. Soc. Nephrol., February 1, 2009; 4(2): 251 - 253. [Full Text] [PDF] |
||||
![]() |
H. N. Ibrahim, C. Wang, A. Ishani, A. J. Collins, and R. N. Foley Screening for Chronic Kidney Disease Complications in US Adults: Racial Implications of a Single GFR Threshold Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1792 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. M. Gutierrez, M. Mannstadt, T. Isakova, J. A. Rauh-Hain, H. Tamez, A. Shah, K. Smith, H. Lee, R. Thadhani, H. Juppner, et al. Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis N. Engl. J. Med., August 7, 2008; 359(6): 584 - 592. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673